Also Known As
Primary Hyperaldosteronism
Primary Aldosteronism
PA
This article was last reviewed on
This article waslast modified on
November 29, 2017.
What is Conn syndrome?

Conn syndrome, also called primary aldosteronism, is an endocrine disorder characterized by excessive secretion of the hormone aldosterone from the adrenal glands. This overproduction leads to the retention of sodium and loss of potassium in the body, resulting in high blood pressure (hypertension).

The adrenal glands are small triangular organs located on the top of the kidneys. They are part of the endocrine system, a group of glands that produce and secrete  hormones that act on and regulate many systems throughout the body. Aldosterone is produced by the outer layer of the adrenal glands, the cortex. It is a hormone that plays an important role in maintaining blood volume, pressure, and electrolyte balance. Its production is normally regulated by renin, an enzyme produced in the kidneys. Aldosterone increases when renin increases due to low blood pressure, decreased blood flow to the kidneys, or a sodium deficiency. When renin decreases, aldosterone also decreases.

With Conn syndrome, excessive aldosterone is produced by one or more benign adrenal tumors, by overactivity of both glands called bilateral adrenal hyperplasia, or for unknown reasons (idiopathic). Rarely, it is caused by a cancerous (malignant) adrenal tumor. In Conn syndrome, aldosterone is produced despite low renin levels. 

Secondary aldosteronism must be distinguished from primary aldosteronism. Secondary aldosteronism is not the same as Conn syndrome because renin levels are high in secondary aldosteronism. Anything that increases renin levels, such as decreased blood flow to the kidneys, low blood pressure, or low sodium levels in the urine, can cause secondary aldosteronism. The most important cause is the narrowing of blood vessels that supply the kidney, termed renal artery stenosis. Other causes of secondary aldosteronism include congestive heart failure, cirrhosis, kidney disease, and toxemia of pregnancy.

Accordion Title
About Conn syndrome (Primary Aldosteronism)
  • Signs and Symptoms

    Regardless of the cause, increased aldosterone can lead to low blood potassium (hypokalemia), increased blood pH (alkalosis), hypertension and, rarely, to hypernatremia. Conn syndrome may cause few, nonspecific symptoms. The symptoms of people with significant hypokalemia and/or hypertension may include: frequent urination, increased thirst, weakness, fatigue, temporary paralysis, visual disturbances, palpitations, headaches, muscle cramps, and tingling. A doctor may suspect Conn syndrome in a patient who is resistant to standard therapies for hypertension. Diagnosing Conn syndrome is important because it represents one of the few causes of hypertension that is potentially curable.

  • Tests

    The goals of testing for Conn syndrome are to identify primary aldosteronism, distinguish between primary and secondary aldosteronism, and distinguish between those causes of Conn syndrome that may benefit from surgical intervention and those that will usually not.

    Laboratory Tests

    • Electrolytes may be measured to look for an electrolyte imbalance, primarily decreased potassium and chloride along with increased carbon dioxide.
    • Doctors will frequently order blood renin tests along with blood and/or 24-hour urine aldosterone tests to help diagnose primary aldosteronism and to monitor the effectiveness of treatment. The ratio of aldosterone to renin (ARR) is used to test for primary aldosteronism. If renin levels are low and aldosterone levels are high, then the ratio will be significantly increased and primary aldosteronism is the likely diagnosis. Based on the results of these tests, a doctor may do a suppression test, using sodium chloride or captopril administration, to see if aldosterone secretion decreases.


    These tests may be followed by a CT (computed tomography) or MRI (magnetic resonance imaging) scan of the adrenal glands to look for a tumor. This process can be complicated as benign adrenal tumors are relatively common, especially as people get older. Many of them do not secrete aldosterone and are found incidentally during procedures performed for other reasons. Determining hyperplasia can also be tricky because the size of normal adrenal glands may vary significantly from one person to the next.

    If hyperplasia or an aldosterone-producing tumor is suspected but not easily locatable, then a doctor may order adrenal venous sampling. In this procedure, blood is collected from the vein that carries blood away from each adrenal gland. These blood samples are tested for aldosterone (sometimes cortisol is also measured and an aldosterone/cortisol ratio is calculated) and then the results from the two adrenal glands are compared. If they are significantly different, then it is likely that an adenoma is located in the gland with the highest aldosterone concentration.

    Non-Laboratory Tests

    • Blood pressure measurement – often the first indicator of possible primary aldosteronism
    • CT (computed tomography) scan or MRI (magnetic resonance imaging) – used to detect adrenal tumors
  • Treatment

    The goals of treating Conn syndrome are to lower blood pressure to normal or near normal levels, decrease blood aldosterone levels, and resolve any electrolyte imbalances. The type(s) of treatment depends on the cause of the excess aldosterone secretion.

    If it is due to a single benign adrenal tumor, then the affected gland may be surgically removed. In many cases, this will completely resolve hypertension and other associated symptoms; however, in other cases, additional treatment will be necessary to fully control blood pressure.

    If the primary aldosteronism is due to a cancerous tumor, which is rare, then organs located next to the affected adrenal gland will need to be evaluated during surgery and more than the adrenal gland may need to be removed.

    If the cause of the primary aldosteronism cannot be determined (idiopathic) or appears to be due to hyperplasia in both adrenal glands, then surgery is usually not recommended. Treatment with a drug such as spironolactone to block the action of aldosterone and with one or more blood pressure drug therapies may be indicated.

    Those affected by Conn syndrome should consult with their doctors and, when indicated, with an endocrinologist (a specialist in the endocrine system). Treatment for primary aldosteronism must often be adjusted to accommodate underlying hypertension, kidney disease, congestive heart failure, and a variety of other disorders. Lifestyle changes, such as dietary changes and exercise, may improve response to hypertension medications.

View Sources

NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.

Sources Used in Current Review

(Reviewed January 2011). Urology Care Foundation. Primary Hyperaldosteronism (Conn's Syndrome). Available online at http://www.urologyhealth.org/urology/index.cfm?article=13 through http://www.urologyhealth.org. Accessed January 2013.

(Reviewed January 2011). MayoClinic.com. Primary aldosteronism. Available online at http://www.mayoclinic.com/health/primary-aldosteronism/DS00563 through http://www.mayoclinic.com. Accessed January 2013.

(Reviewed July 2011). PubMed Health. Hyperaldosteronism - Primary and Secondary. Available online at http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001371/ through http://www.ncbi.nlm.nih.gov. Accessed January 2013.

(Updated August 2012). Medscape. Primary Aldosteronism. Available online at http://emedicine.medscape.com/article/127080-overview through http://emedicine.medscape.com. Accessed January 2013.

Merck Manual. Primary aldosteronism. Available online through http://www.merckmanuals.com. Accessed January 2013.

Sources Used in Previous Reviews

Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.

Plouin, P. et. al. (2004). Trends In The Prevalence Of Primary Aldosteronism, Aldosterone-Producing Adenomas, And Surgically Correctable Aldosterone-Dependent Hypertension. Nephrol Dial Transplant (2004) 19: 774-777 [On-line journal]. Available online at http://ndt.oxfordjournals.org/cgi/content/full/19/4/774 through http://ndt.oxfordjournals.org.

(© 1995-2005) Hyperaldosteronism. The Merck Manual- Second Home Edition [On-line information]. Available online at http://www.merck.com/mmhe/sec13/ch164/ch164e.html through http://www.merck.com.

Jain, T. (2004 February 2). Hyperaldosteronism - primary and secondary. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000330.htm.

Khan, A. et. al., (2005 September 8, Updated). Hyperaldosteronism. EMedicine [On-line information]. Available online at http://www.emedicine.com/radio/topic354.htm through http://www.emedicine.com.

Onusko, E. (2003, January 1). Diagnosing Secondary Hypertension. American Family Physician [On-line journal]. Available online at http://www.aafp.org/afp/20030101/67.html through http://www.aafp.org.

Mrotek, J., and Chase, C. [Henwood, M. and Annaswamy, R., Editors] (2005 January, Review). Endo 101, The Endocrine System, Hormones, and Glands. The Hormone Foundation [On-line information]. Available online at http://www.hormone.org/endo101/endo101_2.html through http://www.hormone.org.

Young, W. (2003 March 7). Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment. Endocrinology Vol. 144, No. 6 2208-2213 [On-line journal]. Available online at http://endo.endojournals.org/cgi/content/full/144/6/2208 through http://endo.endojournals.org.

(© 2002). Conn's syndrome. Center for Pancreatic and Biliary Disease, University of Southern California, Department of Surgery [On-line information]. Available online through http://www.surgery.usc.edu.

Clarke, W. and Dufour, D. R., Editors (© 2006). Contemporary Practice in Clinical Chemistry: AACC Press, Washington, DC. Pp 380-381.

Thomas, Clayton L., Editor (© 1997). Taber's Cyclopedic Medical Dictionary, 18TH Edition: F.A. Davis Company, Philadelphia, PA. Pp 432.

Jabbour, S. (Updated 2007 August 9). Conn Syndrome. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/117280-overview through http://emedicine.medscape.com. Accessed 1/18/09.